Premium
Optimization of concomitant medication in Fabry cardiomyopathy
Author(s) -
Close Lydia,
Elliott Perry
Publication year - 2007
Publication title -
acta pædiatrica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.772
H-Index - 115
eISSN - 1651-2227
pISSN - 0803-5253
DOI - 10.1111/j.1651-2227.2007.00215.x
Subject(s) - medicine , fabry disease , enzyme replacement therapy , concomitant , cardiomyopathy , heart failure , stroke (engine) , chest pain , atrial fibrillation , disease , intensive care medicine , cardiology , heart disease , mechanical engineering , engineering
We describe a male patient with Fabry disease and use this case study to illustrate the importance of a detailed cardiovascular evaluation and the role of supportive therapy in routine management of the disease. The major areas of discussion include the management of exertional chest pain, progressive heart failure and the diagnosis and treatment of atrial and ventricular arrhythmia. Conclusion: In the era of enzyme replacement therapy, conventional pharmacological and device‐based therapies remain central to the management of cardiovascular symptoms and the prevention of complications, such as arrhythmia and stroke.